{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:39:14Z","timestamp":1789123154605,"version":"build-2803163510"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.aohep.2026.102440","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:52:02Z","timestamp":1789120322000},"page":"102440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extrahepatic endocrine manifestations of chronic HCV infection"],"prefix":"10.1016","author":[{"given":"Katerina","family":"Stefanaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymios-Leonidas","family":"Kaltsounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodanthi","family":"Syrigou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos D.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsiodras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0082-634X","authenticated-orcid":false,"given":"Dimitrios S.","family":"Karagiannakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2026.102440_bib0001","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.aohep.2026.102440_bib0002","first-page":"1","article-title":"The origin of hepatitis C virus","volume":"369","author":"Simmonds","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.aohep.2026.102440_bib0003","doi-asserted-by":"crossref","first-page":"e1254","DOI":"10.1093\/infdis\/jiae253","article-title":"Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals","volume":"230","author":"Mbisa","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.aohep.2026.102440_bib0004","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2468-1253(23)00408-9","article-title":"WHO hepatitis C elimination targets: the global equity challenge","volume":"9","author":"Heath","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0006","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0007","doi-asserted-by":"crossref","DOI":"10.5501\/wjv.v13.i1.89469","article-title":"Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999-2019)","volume":"13","author":"Ali","year":"2024","journal-title":"World J Virol"},{"key":"10.1016\/j.aohep.2026.102440_bib0008","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jhep.2017.02.010","article-title":"Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection","volume":"66","author":"Ramos-Casals","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11154-017-9440-1","article-title":"Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature","volume":"1","author":"Fabiani","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.aohep.2026.102440_bib0010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/apt.15131","article-title":"Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia","volume":"49","author":"Younossi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2026.102440_bib0011","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2026.102440_bib0012","doi-asserted-by":"crossref","first-page":"16197","DOI":"10.3748\/wjg.v20.i43.16197","article-title":"Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?","volume":"20","author":"Khoury","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0013","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/jgh.12837","article-title":"Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma","volume":"30","author":"Caviglia","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0014","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep4.1049","article-title":"Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy","volume":"1","author":"Reau","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2026.102440_bib0015","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/0016-5085(94)90547-9","article-title":"Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C","volume":"107","author":"Koskinas","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2026.102440_bib0016","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jhep.2010.03.030","article-title":"Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: Possible role for molecular mimicry","volume":"53","author":"Sutti","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0017","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000282068","article-title":"Cytochrome P450 2D6 as a Model Antigen","volume":"28","author":"Christen","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.aohep.2026.102440_bib0018","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0049-0172(97)80005-4","article-title":"Hepatitis C virus infection and autoimmunity","volume":"26","author":"McMurray","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.aohep.2026.102440_bib0019","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","article-title":"Cacoub PP. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation","volume":"46","author":"Saadoun","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.aohep.2026.102440_bib0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.leu.2404201","article-title":"HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations","volume":"20","author":"De Re","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.aohep.2026.102440_bib0021","first-page":"695","article-title":"Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinical Manifestations, and New Therapies","volume":"3","author":"Schamberg","year":"2007","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.aohep.2026.102440_bib0022","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2008-12-193664","article-title":"Molecular mimicry and immune thrombocytopenia","volume":"113","author":"Aster","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.aohep.2026.102440_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17474124.2020.1708191","article-title":"Hepatitis C, systemic inflammation, and oxidative stress: correlations with metabolic diseases","volume":"14","author":"Sevastianos","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0024","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/gut.2003.038364","article-title":"Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins","volume":"53","author":"N\u00fa\u00f1ez","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2026.102440_bib0025","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10620-010-1395-y","article-title":"HCV-Related Proteins Activate Kupffer Cells Isolated from Human Liver Tissues","volume":"56","author":"Hosomura","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2026.102440_bib0026","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/jmv.21269","article-title":"Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection","volume":"80","author":"Bartolom\u00e9","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.aohep.2026.102440_bib0027","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1089\/thy.2012.0507","article-title":"Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis","volume":"23","author":"Blackard","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.aohep.2026.102440_bib0028","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.510280531","article-title":"Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative-strand viral rna in various tissues","volume":"28","author":"Laskus","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102440_bib0029","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12985-017-0905-3","article-title":"A preliminary analysis of hepatitis C virus in pancreatic islet cells","volume":"14","author":"Blackard","year":"2017","journal-title":"Virol J"},{"key":"10.1016\/j.aohep.2026.102440_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.750380","article-title":"Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism","volume":"12","author":"Ferrari","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.aohep.2026.102440_bib0031","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/1744666X.2015.997214","article-title":"Virus-driven autoimmunity and lymphoproliferation: The example of HCV infection","volume":"11","author":"Zignego","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.aohep.2026.102440_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/935131","article-title":"Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection","volume":"2014","author":"Fallahi","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.aohep.2026.102440_bib0033","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ncpendmet1027","article-title":"Endocrine manifestations of hepatitis C virus infection","volume":"5","author":"Antonelli","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.aohep.2026.102440_bib0034","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4254\/wjh.v7.i3.327","article-title":"Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin\u2019s lymphoma, and cancer","volume":"7","author":"Ferri","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0035","doi-asserted-by":"crossref","first-page":"J322","DOI":"10.1016\/j.jaut.2009.11.008","article-title":"Hepatitis C and interferon induced thyroiditis","volume":"34","author":"Tomer","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.aohep.2026.102440_bib0036","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.aohep.2026.102440_bib0037","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11154-018-9475-y","article-title":"Endocrine disorders associated with hepatitis C virus chronic infection","volume":"19","author":"Colaci","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.aohep.2026.102440_bib0038","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: Clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.aohep.2026.102440_bib0039","first-page":"e305","article-title":"HCV-related autoimmune disorders in HCV chronic infection","volume":"164","author":"Ferrari","year":"2013","journal-title":"Clin Ter"},{"key":"10.1016\/j.aohep.2026.102440_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","article-title":"Thyroid disorders in chronic hepatitis C","volume":"117","author":"Antonelli","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.aohep.2026.102440_bib0041","article-title":"Prevalence of Thyroid Dysfunction in Patients With Hepatitis C","volume":"13","author":"Nazary","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.aohep.2026.102440_bib0042","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.aohep.2026.102440_bib0043","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1600-0676.2001.210506.x","article-title":"HCV and cancer: a case-control study in a high-endemic area","volume":"21","author":"Montella","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.aohep.2026.102440_bib0044","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/17246008211056959","article-title":"The association of hepatitis C virus infection and thyroid disease: A systematic review and meta-analysis","volume":"36","author":"Wang","year":"2021","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.aohep.2026.102440_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajg.2017.01.003","article-title":"Hepatitis C virus infection and risk of thyroid cancer: A systematic review and meta-analysis","volume":"18","author":"Wang","year":"2017","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0046","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2008.08.001","article-title":"HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV-induced thyroid autoimmunity","volume":"31","author":"Akeno","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.aohep.2026.102440_bib0047","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2893.2005.00669.x","article-title":"Hepatitis C and steatosis: a reappraisal","volume":"13","author":"Lonardo","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.aohep.2026.102440_bib0048","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0168-8278(12)60007-5","article-title":"The interaction of metabolic factors with HCV infection: Does it matter?","volume":"56","author":"Bugianesi","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0049","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/v5051292","article-title":"Hepatitis C virus, cholesterol and lipoproteins-Impact for the viral life cycle and pathogenesis of liver disease","volume":"5","author":"Felmlee","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.aohep.2026.102440_bib0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/gut.2006.091983","article-title":"Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt","volume":"56","author":"Marzouk","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2026.102440_bib0051","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.2337\/db10-0704","article-title":"Activation of peroxisome proliferator-activated receptor-\u03b2\/-\u03b4 (PPAR-\u03b2\/-\u03b4) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes","volume":"60","author":"Serrano-Marco","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.aohep.2026.102440_bib0052","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3748\/wjg.v23.i9.1697","article-title":"Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review","volume":"23","author":"Desbois","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0053","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3748\/wjg.v20.i11.2888","article-title":"Interaction between hepatitis C virus and metabolic factors","volume":"20","author":"Kawaguchi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0054","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.aohep.2026.102440_bib0055","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/JVI.01672-07","article-title":"Hepatitis C Virus Core Protein Upregulates Serine Phosphorylation of Insulin Receptor Substrate-1 and Impairs the Downstream Akt\/Protein Kinase B Signaling Pathway for Insulin Resistance","volume":"82","author":"Banerjee","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2026.102440_bib0056","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.21634","article-title":"The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms","volume":"45","author":"Pazienza","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102440_bib0057","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.aohep.2026.102440_bib0058","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jhep.2008.12.029","article-title":"HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters","volume":"50","author":"Kasai","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0059","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fmicb.2011.00278","article-title":"Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders","volume":"2","author":"Shoji","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.aohep.2026.102440_bib0060","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1128\/JVI.00050-12","article-title":"Hepatitis C Virus Activates the mTOR\/S6K1 Signaling Pathway in Inhibiting IRS-1 Function for Insulin Resistance","volume":"86","author":"Bose","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2026.102440_bib0061","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/07315724.2015.1072756","article-title":"Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes","volume":"35","author":"Oliveira","year":"2016","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.aohep.2026.102440_bib0062","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2036.2009.04079.x","article-title":"Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis","volume":"30","author":"Petta","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2026.102440_bib0063","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1600-6143.2009.02642.x","article-title":"Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C","volume":"9","author":"Veldt","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.aohep.2026.102440_bib0064","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/pathophysiology29030024","article-title":"Increased Insulin Resistance in Hepatitis-C Infection\u2014Association with Altered Hepatic Function Testing","volume":"29","author":"Mishra","year":"2022","journal-title":"Pathophysiology"},{"key":"10.1016\/j.aohep.2026.102440_bib0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2010.04.035","article-title":"Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis","volume":"53","author":"Nkontchou","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0066","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bjid.2013.02.009","article-title":"Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: Systematic literature review and meta-analysis","volume":"17","author":"Laurito","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.aohep.2026.102440_bib0067","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1348-0421.13023","article-title":"Hepatitis C virus, insulin resistance, and diabetes: A review","volume":"66","author":"Alzahrani","year":"2022","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.aohep.2026.102440_bib0068","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1590\/1806-9282.20210752","article-title":"Hepatitis C virus eradication on glycemic control and insulin resistance","volume":"67","author":"De Lima Carvalhal","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.aohep.2026.102440_bib0069","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3748\/wjg.v27.i13.1267","article-title":"Metabolic complications of hepatitis C virus infection","volume":"27","author":"Chaudhari","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0070","first-page":"273","article-title":"Hepatitis C Virus-Infected Patients Are \u2018Spared\u2019 from the Metabolic Syndrome but Not from Insulin Resistance. A Comparative Study of Nonalcoholic Fatty Liver Disease and Hepatitis C Virus-Related Steatosis","volume":"23","author":"Lonardo","year":"2009","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0071","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2036.2007.03538.x","article-title":"Archimandritis AJ. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis","volume":"27","author":"Tsochatzis","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2026.102440_bib0072","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s10620-015-3760-3","article-title":"Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review","volume":"60","author":"Dyal","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2026.102440_bib0073","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10620-015-3983-3","article-title":"Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review","volume":"61","author":"Dyal","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2026.102440_bib0074","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102440_bib0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jgh.12705","article-title":"Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders","volume":"30","author":"Chang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0076","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.3748\/wjg.v11.i22.3357","article-title":"Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection","volume":"11","author":"Liu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0077","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajg.2012.05.001","article-title":"Serum leptin level and its association with fatigue in patients with chronic hepatitis C virus infection","volume":"13","author":"El-Gindy","year":"2012","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0078","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hep.21703","article-title":"Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines","volume":"46","author":"Cua","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102440_bib0079","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1111\/j.1572-0241.2000.03294.x","article-title":"Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C","volume":"95","author":"Giannini","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0080","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.3748\/wjg.v17.i46.5097","article-title":"Zouboulis-Vafiadis I. Serum leptin and ghrelin in chronic hepatitis C patients with steatosis","volume":"17","author":"Pavlidis","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0081","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2893.2003.00483.x","article-title":"The severity of liver fibrosis is associated with high leptin levels in chronic Hepatitis C","volume":"11","author":"Piche","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.aohep.2026.102440_bib0082","first-page":"289","article-title":"Association between Leptin, Metabolic Factors and Liver Histology in Patients with Chronic Hepatitis C","volume":"21","author":"Myers","year":"2007","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21218308","article-title":"Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration, and Disease Progression","volume":"21","author":"Chang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2026.102440_bib0084","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.metabol.2015.11.006","article-title":"Adipokines in nonalcoholic fatty liver disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2026.102440_bib0085","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/j.1572-0241.2005.00311.x","article-title":"High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection","volume":"100","author":"Wang","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102440_bib0086","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1365-2036.2006.03114.x","article-title":"Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin\/tumour necrosis factor-\u03b1 in chronic hepatitis C patients","volume":"24","author":"Durante-Mangoni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2026.102440_bib0087","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1684\/ecn.2018.0413","article-title":"Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis","volume":"29","author":"Bastard","year":"2018","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.aohep.2026.102440_bib0088","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.21873\/anticanres.11103","article-title":"Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation","volume":"36","author":"Shen","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.aohep.2026.102440_bib0089","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/jgh.12719","article-title":"Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients","volume":"30","author":"Nakagawa","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026840","article-title":"Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection","volume":"6","author":"Sumie","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2026.102440_bib0091","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5114\/pjp.2012.32767","article-title":"Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy","volume":"63","author":"Kukla","year":"2012","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.aohep.2026.102440_bib0092","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","article-title":"Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin Resistance","volume":"138","author":"Milner","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2026.102440_bib0093","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2119\/molmed.2010.00105","article-title":"Potential Role of Leptin, Adiponectin and Three Novel Adipokines\u2014Visfatin, Chemerin and Vaspin\u2014in Chronic Hepatitis","volume":"17","author":"Kukla","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.aohep.2026.102440_bib0094","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jfma.2023.01.011","article-title":"TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes","volume":"122","author":"Yu","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.aohep.2026.102440_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.aohep.2026.102440_bib0096","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102440_bib0097","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aohep.2026.102440_bib0098","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/jvh.12815","article-title":"Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea, 2002-2013: A population-based cohort study","volume":"25","author":"Choi","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.aohep.2026.102440_bib0099","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/medicina61040614","article-title":"A Real-World Analysis of the Population with Hepatitis C Virus Infection Affected by Type 2 Diabetes in Italy: Patients\u2019 Characteristics, Comorbidity Profiles and Treatment Patterns","volume":"61","author":"Giannini","year":"2025","journal-title":"Medicina (Kaunas)."},{"key":"10.1016\/j.aohep.2026.102440_bib0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jdiacomp.2010.06.004","article-title":"Substantially increased risk of cancer in patients with diabetes mellitus: A systematic review and meta-analysis of epidemiologic evidence in Japan","volume":"24","author":"Noto","year":"2010","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.aohep.2026.102440_bib0101","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies","volume":"130","author":"Wang","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.aohep.2026.102440_bib0102","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/hep.22251","article-title":"Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus","volume":"47","author":"Veldt","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102440_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18425","article-title":"Presence of diabetes further heightens hepatocellular carcinoma risk in patients with hepatitis B or hepatitis C virus-related cirrhosis: A meta-analysis","volume":"9","author":"Zang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.aohep.2026.102440_bib0104","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2337\/diacare.28.4.940","article-title":"Hepatitis C Virus Infection and Human Pancreatic \u03b2-Cell Dysfunction","volume":"28","author":"Masini","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2026.102440_bib0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/CS20190900","article-title":"Chronic hepatitis C virus infection impairs insulin secretion by regulation of p38\u03b4 MAPK-dependent exocytosis in pancreatic \u03b2-cells","volume":"134","author":"Chen","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.aohep.2026.102440_bib0106","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/ijms17060803","article-title":"NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations","volume":"17","author":"Adinolfi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2026.102440_bib0107","article-title":"Associations between type 2 diabetes mellitus and chronic liver diseases: evidence from a Mendelian randomization study in Europeans and East Asians","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.aohep.2026.102440_bib0108","doi-asserted-by":"crossref","DOI":"10.1111\/jog.70015","article-title":"Association of hepatitis C virus infection with risk of gestational diabetes mellitus: A systematic review and meta-analysis","volume":"51","author":"Liu","year":"2025","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.aohep.2026.102440_bib0109","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/AOG.0000000000005703","article-title":"Pregnancy Outcomes in Patients With Hepatitis C Virus Infection","volume":"144","author":"Hughes","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.aohep.2026.102440_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291994","article-title":"Norris AH. Maternal hepatitis C virus infection and three adverse maternal outcomes in the United States","volume":"18","author":"Hood","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2026.102440_bib0111","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40618-022-01909-0","article-title":"Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity","volume":"46","author":"Rodia","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.aohep.2026.102440_bib0112","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12072-018-9845-2","article-title":"High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct-acting antiviral therapy","volume":"12","author":"Eletreby","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2026.102440_bib0113","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40121-017-0171-0","article-title":"Effect of Hepatitis C Treatment with Ombitasvir\/Paritaprevir\/R\u202f+\u202fDasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials","volume":"6","author":"Mehta","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.aohep.2026.102440_bib0114","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4093\/dmj.2017.41.4.316","article-title":"Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4","volume":"41","author":"Dawood","year":"2017","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.aohep.2026.102440_bib0115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2018.11.022","article-title":"Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events","volume":"156","author":"Butt","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2026.102440_bib0116","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/dom.14168","article-title":"Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study","volume":"22","author":"Adinolfi","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.aohep.2026.102440_bib0117","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.14631","article-title":"Direct-Acting Antivirals and Risk of Hepatitis C Extrahepatic Manifestations","volume":"8","author":"Jeong","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.aohep.2026.102440_bib0118","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc17-0485","article-title":"Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus","volume":"40","author":"Hum","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2026.102440_bib0119","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/MS9.0000000000003081","article-title":"Directly acting antivirals improve insulin resistance in nondiabetic patients with hepatitis C: a systematic review and meta-analysis","volume":"87","author":"Lamichhane","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.aohep.2026.102440_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/kjm2.70067","article-title":"Effects of Sofosbuvir\/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan","volume":"41","author":"Wang","year":"2025","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.aohep.2026.102440_bib0121","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jvh.13984","article-title":"The role of treatment of hepatitis C with direct-acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta-analysis","volume":"31","author":"Chen","year":"2024","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.aohep.2026.102440_bib0122","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1111\/liv.14905","article-title":"Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus\/diabetic individuals with chronic hepatitis or with cirrhosis","volume":"41","author":"Cacciola","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2026.102440_bib0123","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/apt.70029","article-title":"Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection","volume":"61","author":"Chang","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2026.102440_bib0124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2017.03.047","article-title":"Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials","volume":"153","author":"Jacobson","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2026.102440_bib0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/07853890.2023.2168745","article-title":"The impact of sofosbuvir\/velpatasvir\/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysis","volume":"55","author":"Hung","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.aohep.2026.102440_bib0126","article-title":"Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study","volume":"76","author":"Pontual","year":"2021","journal-title":"Clinics (Sao Paolo)"},{"key":"10.1016\/j.aohep.2026.102440_bib0127","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/hep4.1851","article-title":"Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study","volume":"6","author":"Valenti","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2026.102440_bib0128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jhep.2022.09.019","article-title":"Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan","volume":"78","author":"Tsai","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102440_bib0129","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021990","article-title":"Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in Taiwan","volume":"9","author":"Lin","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.aohep.2026.102440_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.52338\/jjogastro.2025.4524","article-title":"Adrenal insufficiency is a common finding in chronic hepatitis C patients regardless of cirrhosis","volume":"9","author":"Ahmed","year":"2025","journal-title":"JJOGastro"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126002607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126002607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:52:21Z","timestamp":1789120341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268126002607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":130,"alternative-id":["S1665268126002607"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102440","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrahepatic endocrine manifestations of chronic HCV infection","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102440"}}